MacroGenics, Inc.
MGNX
$1.39
$0.1310.32%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 155.26% | 16.68% | -73.10% | -73.78% | -61.33% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 155.26% | 16.68% | -73.10% | -73.78% | -61.33% |
| Cost of Revenue | 5.42% | 7.82% | -10.76% | -34.50% | -37.61% |
| Gross Profit | 111.91% | 77.50% | -10,385.81% | -141.11% | -20.10% |
| SG&A Expenses | 36.13% | 4.68% | -3.81% | -5.07% | -11.47% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.78% | 8.94% | -4.43% | -12.23% | -16.96% |
| Operating Income | 34.28% | -0.17% | -104.22% | -96.95% | -38.57% |
| Income Before Tax | -628.88% | -295.96% | -1,930.74% | 74.55% | 92.44% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -639.30% | -295.96% | -1,930.74% | 74.55% | 92.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -639.30% | -295.96% | -1,930.74% | 74.55% | 92.44% |
| EBIT | 34.28% | -0.17% | -104.22% | -96.95% | -38.57% |
| EBITDA | 35.03% | -3.94% | -124.03% | -115.41% | -44.77% |
| EPS Basic | -637.84% | -295.19% | -1,950.55% | 75.16% | 92.54% |
| Normalized Basic EPS | -1,024.18% | -295.21% | -1,950.95% | 75.15% | 92.54% |
| EPS Diluted | -570.80% | -299.09% | -2,107.68% | 73.95% | 91.74% |
| Normalized Diluted EPS | -975.74% | -297.07% | -2,044.10% | 74.70% | 92.20% |
| Average Basic Shares Outstanding | 1.12% | 1.02% | 0.92% | 0.80% | 0.81% |
| Average Diluted Shares Outstanding | 0.90% | 0.80% | 0.87% | 1.07% | 1.07% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |